Position in MRK
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$10,898,342
+$897,071 QoQ
Shares Held
84,812
+2.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#720
of 3,768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Summit Trail Advisors, LLC holds $121,589,141 across 15 Drug Manufacturers - General names. MRK ranks #4 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
29,075 | $34,873,430 | |
| 2 | JNJ |
Johnson & Johnson
|
102,279 | $25,975,797 | |
| 3 | ABBV |
AbbVie Inc.
|
66,840 | $16,819,617 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
84,812 | $10,898,342 | |
| 5 | AMGN |
Amgen Inc
|
16,519 | $5,981,860 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
43,955 | $5,553,274 | |
| 7 | PFE |
Pfizer Inc
|
209,089 | $5,034,863 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
71,425 | $4,115,508 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,898,342 | 84,812 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $10,001,271 | 83,143 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $7,591,561 | 72,122 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,892,499 | 82,122 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,259,152 | 66,437 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,460,549 | 60,835 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $5,573,068 | 56,022 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $3,960,291 | 34,874 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,049,621 | 32,711 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,455,555 | 33,767 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $2,838,771 | 26,039 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,820,006 | 27,392 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $2,779,283 | 24,086 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $1,880,868 | 17,679 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $1,676,676 | 15,112 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,231,171 | 14,296 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,103,430 | 12,103 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $845,443 | 10,304 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $586,985 | 7,659 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $656,987 | 8,747 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $568,965 | 7,316 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $461,383 | 5,985 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $580,452 | 7,096 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $754,181 | 9,092 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $531,798 | 6,877 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $476,335 | 6,191 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||